This gene encodes a member of a family of proteins that feature C2H2-type zinc finger domains. The encoded protein is a transcriptional repressor that acts as an effector of transforming growth factor beta signaling. Activity of this protein may inhibit the growth of cancers, particularly pancreatic cancer. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
Forensic Context
A study in humans demonstrated that the KLF10 shows an up-regulated expression pattern after death and was used as a positive-coefficient predictor in a post-mortem interval (PMI) estimation model, which achieved a root mean square error of 4.75 hours [Antiga et al. DOI:10.1038/s41598-021-96095-z]. In domestic swine, research on myocardial infarction identified the KLF10 as being induced in the border and ischemic zones of the heart one day after injury, highlighting its role in the transcriptional response to ischemia [Kaikkonen et al. DOI:10.1161/CIRCGENETICS.117.001702]. A study in mice demonstrated that the KLF10 mRNA increased within 24 hours post-traumatic brain injury in the cortex [Dash et al. DOI:10.23/B:NERE.0000023614.30084.eb].